Adverse Drug Reactions
UCB Announces Positive Top-Line Phase III Results for Keppra as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age
Published in Health Business Week, May 11th, 2007
UCB today announced positive top-line results from a phase III, double-blind, randomized, multi-centre, placebo-controlled study evaluating the efficacy and tolerability of Keppra(R) (levetiracetam) (20-50 mg/kg/day) as adjunctive therapy in the treatment of partial onset seizures in children (n=116) from one month to less than four years of age. Compared with placebo, Keppra(R) was shown to significantly reduce the frequency of partial onset seizures in these paediatric patients with consistent results across all stratified age groups.
Commenting on the results, Jes's Eric Pi'a-Garza M.D., Professor of Paediatric Neurology & Director Pediatric Epilepsy Clinical Trials,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2007-05-11)
More Articles from Health Business Week
- 3D Systems Corporation
3D Systems Recruits Chief Financial Officer - AARP
Calls for Rx Marketing Reform to Lower Cost of Prescription Drugs - ABB
ABB Announces PAT Solution for the Life Sciences Industry - ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Announces Exercise of Over-Allotment by Underwriters - Aceto Corporation
Aceto Schedules Third Quarter Financial Results News Release and Conference Call - Acne Vulgaris
Acne Sufferers Trading Off Youthful Skin for Treating Acne - Two Linked Conditions - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
